These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


312 related items for PubMed ID: 24631088

  • 1. Early protection against foot-and-mouth disease virus in cattle using an inactivated vaccine formulated with Montanide ESSAI IMS D 12802 VG PR adjuvant.
    Quattrocchi V, Pappalardo JS, Langellotti C, Smitsaart E, Fondevila N, Zamorano P.
    Vaccine; 2014 Apr 17; 32(19):2167-72. PubMed ID: 24631088
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant effect of Cliptox on the protective immune response induced by an inactivated vaccine against foot and mouth disease virus in mice.
    Batista A, Quattrocchi V, Olivera V, Langellotti C, Pappalardo JS, Di Giacomo S, Mongini C, Portuondo D, Zamorano P.
    Vaccine; 2010 Aug 31; 28(38):6361-6. PubMed ID: 20637310
    [Abstract] [Full Text] [Related]

  • 3. Montanide ISA™ 201 adjuvanted FMD vaccine induces improved immune responses and protection in cattle.
    Dar P, Kalaivanan R, Sied N, Mamo B, Kishore S, Suryanarayana VV, Kondabattula G.
    Vaccine; 2013 Jul 18; 31(33):3327-32. PubMed ID: 23735678
    [Abstract] [Full Text] [Related]

  • 4. Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.
    Pan L, Zhang Z, Lv J, Zhou P, Hu W, Fang Y, Chen H, Liu X, Shao J, Zhao F, Ding Y, Lin T, Chang H, Zhang J, Zhang Y, Wang Y.
    Int J Nanomedicine; 2014 Jul 18; 9():5603-18. PubMed ID: 25506214
    [Abstract] [Full Text] [Related]

  • 5. No significant differences in the breadth of the foot-and-mouth disease serotype A vaccine induced antibody responses in cattle, using different adjuvants, mixed antigens and different routes of administration.
    Tekleghiorghis T, Weerdmeester K, van Hemert-Kluitenberg F, Moormann RJ, Dekker A.
    Vaccine; 2014 Sep 15; 32(41):5330-6. PubMed ID: 25092634
    [Abstract] [Full Text] [Related]

  • 6. Enhanced protection against FMDV in cattle after prime- boost vaccination based on mucosal and inactivated FMD vaccine.
    Khalifa ME, El-Deeb AH, Zeidan SM, Hussein HA, Abu-El-Naga HI.
    Vet Microbiol; 2017 Oct 15; 210():1-7. PubMed ID: 29103677
    [Abstract] [Full Text] [Related]

  • 7. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
    Barrera J, Schutta C, Pisano M, Grubman MJ, Brake DA, Miller T, Kamicker BJ, Olutunmbi F, Ettyreddy D, Brough DE, Butman BT, Neilan JG.
    Vaccine; 2018 Feb 14; 36(8):1078-1084. PubMed ID: 29358056
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
    Singanallur NB, Pacheco JM, Arzt J, Stenfeldt C, Fosgate GT, Rodriguez L, Vosloo W.
    Antiviral Res; 2017 Sep 14; 145():114-122. PubMed ID: 28780422
    [Abstract] [Full Text] [Related]

  • 9. Systemic Foot-and-Mouth Disease Vaccination in Cattle Promotes Specific Antibody-Secreting Cells at the Respiratory Tract and Triggers Local Anamnestic Responses upon Aerosol Infection.
    Pega J, Di Giacomo S, Bucafusco D, Schammas JM, Malacari D, Barrionuevo F, Capozzo AV, Rodríguez LL, Borca MV, Pérez-Filgueira M.
    J Virol; 2015 Sep 14; 89(18):9581-90. PubMed ID: 26157128
    [Abstract] [Full Text] [Related]

  • 10. Coinjection of a vaccine and anti-viral agents can provide fast-acting protection from foot-and-mouth disease.
    You SH, Kim T, Choi JH, Park G, Lee KN, Kim B, Lee MH, Kim HS, Kim SM, Park JH.
    Antiviral Res; 2017 Jul 14; 143():195-204. PubMed ID: 28454913
    [Abstract] [Full Text] [Related]

  • 11. Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion.
    Fowler VL, Knowles NJ, Paton DJ, Barnett PV.
    Vaccine; 2010 Apr 26; 28(19):3428-34. PubMed ID: 20199761
    [Abstract] [Full Text] [Related]

  • 12. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
    Moraes MP, Segundo FD, Dias CC, Pena L, Grubman MJ.
    Vaccine; 2011 Nov 28; 29(51):9431-40. PubMed ID: 22027486
    [Abstract] [Full Text] [Related]

  • 13. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
    Capozzo AV, Wilda M, Bucafusco D, de los Ángeles Lavoria M, Franco-Mahecha OL, Mansilla FC, Pérez-Filgueira DM, Grigera PR.
    Antiviral Res; 2011 Nov 28; 92(2):219-27. PubMed ID: 21889542
    [Abstract] [Full Text] [Related]

  • 14. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ.
    Biologicals; 2005 Dec 28; 33(4):227-34. PubMed ID: 16289996
    [Abstract] [Full Text] [Related]

  • 15. Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge.
    Schutta C, Barrera J, Pisano M, Zsak L, Grubman MJ, Mayr GA, Moraes MP, Kamicker BJ, Brake DA, Ettyreddy D, Brough DE, Butman BT, Neilan JG.
    Vaccine; 2016 Jun 08; 34(27):3214-3220. PubMed ID: 26707216
    [Abstract] [Full Text] [Related]

  • 16. Co-inoculation of baculovirus and FMDV vaccine in mice, elicits very early protection against foot and mouth disease virus without interfering with long lasting immunity.
    Quattrocchi V, Molinari P, Langellotti C, Gnazzo V, Taboga O, Zamorano P.
    Vaccine; 2013 May 31; 31(24):2713-8. PubMed ID: 23588086
    [Abstract] [Full Text] [Related]

  • 17. Use of new adjuvants in an emergency vaccine against foot-and-mouth disease virus: evaluation of conferred immunity.
    Quattrocchi V, Bianco V, Fondevila N, Pappalardo S, Sadir A, Zamorano P.
    Dev Biol (Basel); 2004 May 31; 119():481-97. PubMed ID: 15742663
    [Abstract] [Full Text] [Related]

  • 18. Role of macrophages in early protective immune responses induced by two vaccines against foot and mouth disease.
    Quattrocchi V, Langellotti C, Pappalardo JS, Olivera V, Di Giacomo S, van Rooijen N, Mongini C, Waldner C, Zamorano PI.
    Antiviral Res; 2011 Nov 31; 92(2):262-70. PubMed ID: 21878353
    [Abstract] [Full Text] [Related]

  • 19. The field effectiveness of routine and emergency vaccination with an inactivated vaccine against foot and mouth disease.
    Elnekave E, Li Y, Zamir L, Even-Tov B, Hamblin P, Gelman B, Hammond J, Klement E.
    Vaccine; 2013 Jan 30; 31(6):879-85. PubMed ID: 23246551
    [Abstract] [Full Text] [Related]

  • 20. Heterogeneity in the Antibody Response to Foot-and-Mouth Disease Primo-vaccinated Calves.
    Di Giacomo S, Brito BP, Perez AM, Bucafusco D, Pega J, Rodríguez L, Borca MV, Pérez-Filgueira M.
    Transbound Emerg Dis; 2015 Jun 30; 62(3):280-7. PubMed ID: 23895140
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.